A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden

unknow

★ 5.0 · 29 reads

Sign in to save this
Request Code
ZLIB.IO18516868
Published
2022
Pages
1
Language
Unknown